Artal Group S.A. - Q2 2022 holdings

$1.87 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .

 Value Shares↓ Weighting
ExitGINKGO BIOWORKS HOLDINGS INC$0-50,000
-100.0%
-0.01%
XP ExitXP INCcl a$0-35,000
-100.0%
-0.04%
DYNS ExitDYNAMICS SPECIAL PURPOSE COR$0-500,000
-100.0%
-0.21%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-200,000
-100.0%
-0.25%
TGTX ExitTG THERAPEUTICS INC$0-800,000
-100.0%
-0.32%
SAGE ExitSAGE THERAPEUTICS INCcall$0-250,000
-100.0%
-0.35%
FMTX ExitFORMA THERAPEUTICS HLDGS INC$0-1,000,000
-100.0%
-0.39%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-200,000
-100.0%
-0.42%
INTC ExitINTEL CORPcall$0-300,000
-100.0%
-0.62%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-800,100
-100.0%
-0.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AGENUS INC42Q3 20231.9%
IRONWOOD PHARMACEUTICALS INC42Q3 20230.3%
ALNYLAM PHARMACEUTICALS INC37Q3 20235.1%
LEXICON PHARMACEUTICALS INC34Q3 202320.6%
AMICUS THERAPEUTICS INC30Q3 20232.7%
BEIGENE LTD28Q3 20237.4%
BK OF AMERICA CORP28Q1 20214.3%
SAGE THERAPEUTICS INC28Q2 20231.9%
AGIOS PHARMACEUTICALS INC28Q2 20201.1%
NEKTAR THERAPEUTICS27Q2 20201.3%

View Artal Group S.A.'s complete holdings history.

Latest significant ownerships (13-D/G)
Artal Group S.A. Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
WEIGHT WATCHERS INTERNATIONAL INCFebruary 13, 201529,443,30051.9%

View Artal Group S.A.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-03-25
42024-03-13
42024-02-29
13F-HR2024-02-09
13F-HR2023-11-13
42023-10-16
13F-HR2023-08-11
42023-06-22
32023-06-15
42023-06-05

View Artal Group S.A.'s complete filings history.

Compare quarters

Export Artal Group S.A.'s holdings